BioVision's BioSimilar Antibodies and ELISA Kits

webinars-10012019

 

Human IgG based monoclonal antibodies (mAbs) are the fastest-growing category of therapeutics for cancer therapy. BioVision is pleased to offer research-grade biosimilar antibodies and ELISA Kits for your research needs. These antibodies can be used as controls for preclinical lead identification and potency assays for the development of novel therapeutics; ELISA Kits can be used to identify biomarker for (non-)response and risk factors for adverse drug reactions.


Check out BioVision’s webinar highlighting on our BioSimilar Antibodies and ELISA Kits.

 

 

Please enter your information to download webinar for BioVision's BioSimilar Antibodies and ELISA Kits.

For more information related this webinar please contact marketing@biovision.com and for any technical inquiry please email tech@biovision.com.